Illumina, Inc. (ETR:ILU)
112.86
+1.16 (1.04%)
At close: Nov 28, 2025
Illumina Revenue
Illumina had revenue of $1.08B USD in the quarter ending September 28, 2025, with 0.37% growth. This brings the company's revenue in the last twelve months to $4.29B, down -2.32% year-over-year. In the year 2024, Illumina had annual revenue of $4.37B, down -2.93%.
Revenue (ttm)
$4.29B
Revenue Growth
-2.32%
P/S Ratio
4.72
Revenue / Employee
$474.86K
Employees
9,030
Market Cap
17.32B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
| Dec 30, 2018 | 3.33B | 581.00M | 21.11% |
| Dec 31, 2017 | 2.75B | 354.00M | 14.76% |
| Jan 1, 2017 | 2.40B | 178.00M | 8.02% |
| Jan 3, 2016 | 2.22B | 358.64M | 19.27% |
| Dec 28, 2014 | 1.86B | 440.18M | 30.97% |
| Dec 29, 2013 | 1.42B | 272.66M | 23.74% |
| Dec 30, 2012 | 1.15B | 92.98M | 8.81% |
| Jan 1, 2012 | 1.06B | 152.79M | 16.93% |
| Jan 2, 2011 | 902.74M | 236.42M | 35.48% |
| Jan 3, 2010 | 666.32M | 93.10M | 16.24% |
| Dec 28, 2008 | 573.23M | 206.43M | 56.28% |
| Dec 30, 2007 | 366.80M | 182.21M | 98.71% |
| Dec 31, 2006 | 184.59M | 111.09M | 151.13% |
| Jan 1, 2006 | 73.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Illumina News
- 11 days ago - Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PRNewsWire
- 19 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 19 days ago - Notable Tuesday Option Activity: ILMN, VKTX, CVNA - Nasdaq
- 19 days ago - ALKS or ILMN: Which Is the Better Value Stock Right Now? - Nasdaq
- 20 days ago - Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation - CNBC
- 20 days ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 23 days ago - Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha